XRP
All compounds
HormoneFertility

HMG

Human Menopausal Gonadotropin (FSH/LH)

Typical Dose
75–150 IU
Route
Injectable
Variants
75 IU

Overview

What is HMG?

HMG combines FSH and LH activity, used in fertility research to support spermatogenesis and ovarian stimulation protocols.

Mechanism of Action

Provides exogenous FSH/LH stimulation, supporting gametogenesis when endogenous gonadotropins are insufficient.

Key Benefits

  • Spermatogenesis support
  • Gonadal restoration after suppression
  • Fertility research

Research Indications

Fertility restorationMost Effective
HPTA recoveryEffective

Research Protocols

Disclaimer

These are commonly discussed research protocols and not medical advice. Consult a healthcare provider before use.

GoalDoseFrequencyRoute
Conservative75 IU2x weeklySubcutaneous
Standard starting dose75 IU3x weeklySubcutaneous
Typical maintenance150 IU3x weeklySubcutaneous
Maximum150 IUEODSubcutaneous

Peptide Interactions

HCG
Synergistic
Clomiphene
Compatible

Side Effects & Safety

Common Side Effects

  • Injection-site reaction
  • Headache
  • Mood swings

Safety Guidelines

  • For laboratory research use only — not for human consumption
  • Store reconstituted vials at 2–8°C, use within 30 days
  • Rotate injection sites to avoid local irritation
  • Discontinue and consult a clinician if adverse reactions occur

Quality Indicators

  • ≥95% purity verified by HPLC
  • Third-party tested for sterility
  • Lyophilized in sealed multi-dose vial
  • Bacteriostatic water reconstitution
  • Refrigerated cold-chain shipping

What to Expect

  1. 1
    Week 1–2
    Hormonal markers shift
  2. 2
    Week 3–8
    Spermatogenesis response
  3. 3
    Week 9–12
    Sustained fertility markers

Need a different compound?

Browse all peptides